Nephro- and neuroprotective effects of rosiglitazone versus glimepiride in normoalbuminuric patients with type 2 diabetes mellitus: a randomized controlled trial

Impaired Tubular Uptake Explains Albuminuria in Early Diabetic Nephropathy

(2009) L. M. Russo et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Effects of pioglitazone on major adverse cardiovascular events in high-risk patients with type 2 diabetes: Results from PROspective pioglitAzone Clinical Trial In macro Vascular Events (PROactive 10)

(2008) Robert Wilcox et al.   AMERICAN HEART JOURNAL

Comparison between single and combined treatment with candesartan and pioglitazone following transient focal ischemia in rat brain

(2008) Kristin Schmerbach et al.   BRAIN RESEARCH

Increased High-Density Lipoprotein Cholesterol Predicts the Pioglitazone-Mediated Reduction of Carotid Intima-Media Thickness Progression in Patients With Type 2 Diabetes Mellitus

(2008) Michael Davidson et al.   CIRCULATION

Resolved: Normal Glomeruli Filter Nephrotic Levels of Albumin

(2008) W. D. Comper et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Tubular function in diabetic children assessed by Tamm-Horsfall protein and glutathione S-transferase

(2008) Peter Holmquist et al.   PEDIATRIC NEPHROLOGY

Effect of Pioglitazone on Cardiovascular Outcome in Diabetes and Chronic Kidney Disease

(2007) C. A. Schneider et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY